FDA NDC Directory · JSON-LD · Markdown

Atropine Sulfate

NDC 63323-580 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryNew Drug Application (innovator) · App NDA209260
Dosage form / routeINJECTION, SOLUTION · ENDOTRACHEAL INTRAMEDULLARY INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active ingredientsATROPINE SULFATE (.4 mg/mL)
Marketing started20170123
Package count1

External sources

Source: openFDA. Public-domain (CC0).